Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-022909)

Filing Details

Accession Number:: 0001209191-12-022909
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-12 17:22:25
Reporting Period:: 2012-04-11

Filing Date:: 2012-04-12
Accepted Time:: 2012-04-12 17:22:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276244	Shuster Mitchell Steiner	175 Toyota Plaza 7Th Floor Memphis TN 38103	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-11	26,585	$3.51	1,994,123	No	4	S	Indirect	By Wife
Common Stock	Disposition	2012-04-12	1,137	$3.50	1,992,986	No	4	S	Indirect	By Wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Wife
No	4	S	Indirect	By Wife

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,129,922	Direct
Common Stock	5,100	Indirect	By Joint Account
Common Stock	134,210	Indirect	By 2010 Trust
Common Stock	134,721	Indirect	By Trust
Common Stock	133,981	Indirect	By Trust
Common Stock	133,741	Indirect	By Trust
Common Stock	133,741	Indirect	By Trust

Footnotes

An aggregate of 26,585 shares of common stock were sold in multiple trades on April 11, 2012 at prices ranging from $3.50 to $3.5209. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.